Doanh Pham, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 14536 Brookhurst St Ste 102, Westminster, CA 92683 Phone: 714-531-2548 Fax: 714-531-2540 |
Dong Bui, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 9559 Bolsa Ave, Suite A, Westminster, CA 92683 Phone: 714-531-4616 Fax: 714-531-4617 |
Mr. Thuy Duc Luu, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 9191 Bolsa Ave, Ste 215 216, Westminster, CA 92683 Phone: 714-897-3300 Fax: 714-897-1653 |
Dr. Thu Hoa Victoria Van, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 15606 Brookhurst St Ste B, Westminster, CA 92683 Phone: 714-531-0000 Fax: 714-531-1006 |
Dr. Son Truong, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 15643 Brookhurst St, Westminster, CA 92683 Phone: 714-839-3099 |
Dr. Thoi Thanh Vo, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 250 Hospital Cir, Westminster, CA 92683 Phone: 714-890-6644 Fax: 714-899-3493 |
Dr. Toufan Rodney Mehryan, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 7955 Westminster Blvd, Westminster, CA 92683 Phone: 714-379-3221 Fax: 714-379-3211 |
News Archive
Americans are making considerable progress in their overall health, according to United Health Foundation's 2013 America's Health RankingsĀ®: A Call to Action for Individuals & Their Communities. Nationwide, Americans improved in the majority of the measures captured by the Rankings.
Among kidney disease patients, earlier care from a nephrologist is associated with a decreased likelihood of developing end-stage renal disease and a lower risk of death during the first year of dialysis, according to a study presented at the American Society of Nephrology's 43rd Annual Meeting and Scientific Exposition.
White House Drug Control Policy Director Michael Botticelli has awarded Boston University School of Medicine's Safe and Competent Opioid Prescribing Education (SCOPE of Pain) program a 2014 National High Intensity Drug Trafficking Area (HIDTA) award for Outstanding Prevention Effort.
Repligen Corporation announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office for a patent covering a recombinant form of Protein A which is identical in structure to the commercial form of Protein A from Staphylococcus aureus which is used in the production of many of the world's approved monoclonal antibodies. The patent, which will remain in force until 2028, covers a new Repligen proprietary product which is now available in commercial quantities.
Data from NHS Test and Trace shows that mass participation events can be conducted safely, but caution must still be taken around specific aspects of event participation.
› Verified 1 days ago